Active Biotech AB
https://www.activebiotech.com/en/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Active Biotech AB
Finance Watch: Four Offerings In One Week As Biopharma Keeps Its IPO Market Lead
Lantern, Avidity, Generation Bio and Vaxcyte launched initial public offerings during the second week of June as biopharma continues to intrigue IPO investors. Also, Blackstone invested $350m in Reata's bardoxolone and Checkmate’s $85m series C led recent VC deals.
BIO 2020 Notebook: Fauci On Price Controls; Biotech's Financing Advantage; Progress Towards Universal Flu Vaccine
News and views from day two of BIO Digital include Jim Greenwood on the prospects for drug development legislation.
BIO 2020 Notebook: Fauci On Price Controls; Biotech's Financing Advantage; Progress Towards Universal Flu Vaccine
News and views from day two of BIO Digital include Jim Greenwood on the prospects for drug development legislation.
Finance Watch: Ayala Launches First Biopharma IPO In May
The cancer drug developer raised $55m. Also, Lyra raised $56m in the last of four biopharma IPOs in April, Biogen sold $3bn worth of debt, Oberland raised a $1.05bn fund and Praxis launched with more than $100m.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals